Practical pharmacoeconomics. An examination of the relationship between non-depression-related costs and uninterrupted Tx.

Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of antidepressant treatment. One previously published study showed that significant savings in office-based serv...

Descripción completa

Detalles Bibliográficos
Publicado en:Formulary Vol. 36; no. 6; pp. 461 - 467
Autores principales: Armstrong EP, Abarca J
Formato: research tables/charts Journal Article
Publicado: MJH Life Sciences Jun2001
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106846911&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106846911
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1082801X
        FRM
      jtl: Formulary
      issn: 1082801X
      maglogo: N
    pubinfo:
      dt: Jun2001
      vid: 36
      iid: 6
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        106846911
        106846911
        2003091975
        106846911
      ppf: 461
      ppct: 6
      formats:
      tig:
        atl: Practical pharmacoeconomics. An examination of the relationship between non-depression-related costs and uninterrupted Tx.
      aug:
        au:
          Armstrong EP
          Abarca J
        affil: Associate Professor, Department of Pharmacy Practice, College of Pharmacy, University of Arizona, Tucson, AZ
      sug:
        subj:
          Antidepressive Agents Therapeutic Use
          Continuity of Patient Care
          Depression Drug Therapy
          Chi Square Test
          Confidence Intervals
          Health Care Costs
          Logistic Regression
          Managed Care Programs Economics
          Odds Ratio
          Funding Source
          Human
      ab: Depression is an important disease for many managed care organizations and can be one of the largest cost drivers in their drug budget. A number of studies have focused on the cost impact of antidepressant treatment. One previously published study showed that significant savings in office-based service costs was likely in patients who completed at least 6 months of antidepressant therapy. The purpose of this study was to determine if these results could be replicated in another managed care population. The methodology from the previously published study was adopted as a framework for this analysis. No analyses in the current study demonstrated that uninterrupted antidepressant treatment was associated with a large reduction in non-depression-related costs.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N